Page last updated: 2024-12-07

4-methylumbelliferyl glucuronide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-methylumbelliferyl glucuronide (4-MUG) is a synthetic substrate commonly used to measure the activity of β-glucuronidase, an enzyme involved in the detoxification and elimination of various compounds in the body. It is synthesized by reacting 4-methylumbelliferone with glucuronic acid. When β-glucuronidase acts on 4-MUG, it hydrolyzes the glucuronic acid moiety, releasing the fluorescent 4-methylumbelliferone, which can be quantified using a fluorometer. 4-MUG is widely employed in research due to its high sensitivity and specificity for β-glucuronidase. It is used in various applications, including assessing the activity of this enzyme in biological samples, studying its role in diseases like cancer and inflammatory bowel disease, and screening for inhibitors of β-glucuronidase.'

4-methylumbelliferone beta-D-glucuronide : A beta-D-glucosiduronic acid having a 4-methylumbelliferyl substituent at the anomeric position. A hyaluronan synthesis inhibitor, it is anti-tumourigenic for various malignant tumours. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID91553
CHEMBL ID1592343
CHEBI ID1904
SCHEMBL ID110946
MeSH IDM0107249

Synonyms (51)

Synonym
4-methylumbelliferyl-beta-d-glucuronide hydrate
MOLMAP_000057 ,
4-methylumbelliferyl glucuronide
4-methylumbelliferone glucuronide
6160-80-1
NCGC00142405-01
4-methylumbelliferyl-beta-d-glucuronide
4-methylumbelliferyl beta-d-glucuronide
AC1L3MB1 ,
(2s,3s,4s,6s,5r)-3,4,5-trihydroxy-6-(4-methyl-2-oxochromen-7-yloxy)-2h-3,4,5,6 -tetrahydropyran-2-carboxylic acid
ST044517 ,
4-methylumbelliferyl beta-glucuronide
4-methyl-2-oxo-2h-1-benzopyran-7-yl beta-d-glucopyranosiduronic acid
hymecromone glucuronide
beta-d-glucopyranosiduronic acid, 4-methyl-2-oxo-2h-1-benzopyran-7-yl
einecs 228-186-0
AC1Q69Y2 ,
CHEMBL1592343
chebi:1904 ,
AKOS016015769
S10914
4-methylumbelliferyl b-d-glucuronide trihydrate
.beta.-d-glucopyranosiduronic acid, 4-methyl-2-oxo-2h-1-benzopyran-7-yl
SCHEMBL110946
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(4-methyl-2-oxo-chromen-7-yl)oxy-tetrahydropyran-2-carboxylic acid
4-methylumbelliferone beta-d-glucuronide
b-d-glucopyranosiduronic acid,4-methyl-2-oxo-2h-1-benzopyran-7-yl
W-201743
4-methylumbelliferyl .beta.-d-glucuronide
mfcd00036772
4-methylumbelliferyl-beta-d-glucuronide, >=99.0% (hplc)
mug supplement, for microbiology
AS-74949
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[(4-methyl-2-oxo-2h-chromen-7-yl)oxy]oxane-2-carboxylic acid
4-methylumbelliferylglucuronide
BBL102001
A901887
4-methylumbelliferyl b-d-glucuronide hydrate
4-methyl-2-oxo-2h-chromen-7-yl beta-d-glucopyranosiduronic acid
STL555799
DTXSID10891502
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-((4-methyl-2-oxo-2h-chromen-7-yl)oxy)tetrahydro-2h-pyran-2-carboxylic acid ,
Q27105523
4-methylumbelliferyl--d-glucuronide
4-methylumbelliferyl beta -d-glucuronide
4-methylumbelliferyl ?-d-glucuronide
CS-0019450
BP-58686
HY-D0935
4-methylumbelliferyl-|a-d-glucuronide
PD008008

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"We describe a new method that uses a fluorogenic bioassay of the beta-glucuronidase conversion of 4-methylumbelliferyl beta-D-glucuronide (MUG) to 4-methylumbelliferone to evaluate the individual toxic effects on Escherichia coli of Al3+, Cr6+, Hg2+ and Li+."( New toxicity determination method that uses fluorescent assay of Escherichia coli.
Carnero, M; Fernández-Crehuet, J; García, A; Gómez, E; Mariscal, A, 1994
)
0.29

Dosage Studied

ExcerptRelevanceReference
" After bolus dosing of preformed 4MUG in the perfusion reservoir of the filtering IPK, the perfusate concentration declined with the terminal half-life of approximately 260 min."( Differential disposition of intra-renal generated and preformed glucuronides: studies with 4-methylumbelliferone and 4-methylumbelliferyl glucuronide in the filtering and nonfiltering isolated perfused rat kidney.
Evans, AM; Knights, KM; Miners, JO; Wang, J, 2011
)
0.58
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
chromogenic compoundColourless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into coloured compounds. They are used in biochemical assays and in diagnosis as indicators, particularly in the form of enzyme substrates.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
hyaluronan synthesis inhibitorAny inhibitor that interferes with the synthesis of hyaluronic acid (HA, also known as hyaluronan).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
coumarins
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
beta-D-glucosiduronic acidA glucosiduronic acid resulting from the formal condensation of any substance with beta-D-glucuronic acid to form a glycosidic bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID893
Chain B, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID893
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency35.48130.177814.390939.8107AID2147
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
glucocerebrosidaseHomo sapiens (human)Potency17.78280.01268.156944.6684AID2101
alpha-galactosidaseHomo sapiens (human)Potency44.66844.466818.391635.4813AID2107
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency35.48130.001815.663839.8107AID894
mitogen-activated protein kinase 1Homo sapiens (human)Potency39.81070.039816.784239.8107AID995
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID19240Partition coefficient of Zwitterion (logD)1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates.
AID18980Log D of compound; LogD at pH 7.41996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates.
AID25845Sugar COOH pKa of compound1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates.
AID19243Partition coefficient of anion (logD)1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (89)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (20.22)18.7374
1990's39 (43.82)18.2507
2000's19 (21.35)29.6817
2010's11 (12.36)24.3611
2020's2 (2.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.69 (24.57)
Research Supply Index4.53 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index26.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.10%)5.53%
Reviews1 (1.10%)6.00%
Case Studies1 (1.10%)4.05%
Observational0 (0.00%)0.25%
Other88 (96.70%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]